COPYRIGHT POLICY

Current Pharmaceutical Research (CPR) is committed to protecting the intellectual property of authors while promoting the widest possible dissemination of scientific knowledge. Under our Open Access publishing framework, authors retain the full copyright of their original work without any restrictions. Upon acceptance of a manuscript, authors grant CPR an exclusive license to publish, reproduce, display, and distribute the final version of the article across all digital platforms, formats, and media globally.

All articles are published under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This licensing framework allows authors and third parties to read, download, share, adapt, and build upon the published work for non-commercial purposes, provided the original author(s) and CPR are properly credited as the initial publication source. Authors do not transfer their copyright ownership to the publisher at any stage of the peer review or publication process.

Furthermore, authors retain unrestricted self-archiving rights. Authors are fully encouraged to deposit all versions of their published manuscript—including the pre-print, accepted version, and final published Publisher's PDF in personal websites, institutional repositories, or subject-based repositories (such as PubMed Central, Zenodo, and ResearchGate) immediately upon publication, provided a direct link to the official published DOI on the CPR journal platform is included.